Solvay sells Caprolactones unit for 200 mln euros

BRUSSELS Mon Oct 15, 2007 2:42am EDT

BRUSSELS Oct 15 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR) said on Monday it had sold its Caprolactones business for 200 million euros ($284.3 million) to Sweden's Perstorp Group.

The transaction is expected to be completed in the fourth quarter of 2007, pending regulatory approvals.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.